Transgene: Balance Sheet of the Liquidity Contract With Natixis Oddo BHF SCA as of June 30, 2022
STRASBOURG, France–(BUSINESS WIRE)–#HBV–Regulatory News:
Under the liquidity contract entrusted by Transgene (Paris:TNG) to Natixis Oddo BHF SCA, as of June 30, 2022, the following resources were managed through the liquidity account:
- 230,257 shares,
- € 227,533.00.
In the first half of 2022, a total of:
| Purchases | 451,259 shares | € 1,036,761 | 747 market transactions |
| Sales | 397,502 shares | € 929,416 | 687 market transactions |
It is recalled that
1. as of December 31, 2021, the following resources were managed through the liquidity account:
– 176,500 shares
– € 334,853.00
2. when the liquidity program was initially established in 2016, the following resources were made available:
– Cash balance of the liquidity contract: € 500,000.00
3. at the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
– 164,183 shares
– € 246,158.00
Contacts
Transgene:
Lucie Larguier
Director Corporate Communications & IR
+33 (0)3 88 27 91 04
[email protected]
